Delivery Order SPE2DR25D2014-SPE2DR26FA2M4
- Not listed
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $37,240.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 14, 2026, with performance based in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,732.24 on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, awarded by the Defense Logistics Agency (DLA), the Department of Defense's supply chain management organization responsible for medical procurement. Performance will be completed...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,447.57 delivery order on January 12, 2026, for the supply of Jardiance 25 mg tablets (90-count packaging) under a firm fixed-price contract type with no set-aside designation. The award, which carries an ultimate completion date of January 13, 2026, is funded by the Defense Logistics Agency (DLA), a defense-focused federal procurement entity responsible for supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,274.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 30, 2025, by the Defense Logistics Agency (DLA) for the supply of Jardiance 10 mg tablets in quantities of 90 units. This firm fixed-price delivery order, valued at $32,598.70, is scheduled for completion by October 31, 2025, and represents a non-set-aside competitive award. The contract will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a $16,489.50 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg on December 10, 2025, with completion scheduled for December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $11,878.85. This competitive, firm fixed-price delivery order is set to be completed by November 7, 2025, and represents a single-line procurement under AmerisourceBergen's larger pharmaceutical supply framework with the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 11, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) valued at $64,915.53. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a Department of Defense component responsible for supplying medical and pharmaceutical products to military and federal healthcare systems. The...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2M4Delivery Order
On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $11,977.20 to AmerisourceBergen Drug Corp for 90-count supplies of Jardiance 25 mg tablets, with completion scheduled for January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and other healthcare commodities to military treatment facilities and veteran healthcare programs. Jardiance is a diabetes management medication commonly prescribed within Department of Defense and Veterans Affairs healthcare systems, making this delivery consistent with the broader mission of the underlying IDC to support military and federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 1/13/26 |